Literature DB >> 35152976

Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer.

Yuan-Shan Zhu1, Jifeng Zhu2.   

Abstract

Long noncoding RNAs (lncRNAs) are defined as noncoding RNA transcripts with a length greater than 200 nucleotides. Research over the last decade has made great strides in our understanding of lncRNAs, especially in the biology of their role in cancer. In this article, we will briefly discuss the biogenesis and characteristics of lncRNAs, then review their molecular and cellular functions in cancer by using prostate and breast cancer as examples. LncRNAs are abundant, diverse, and evolutionarily, less conserved than protein-coding genes. They are often expressed in a tumor and cell-specific manner. As a key epigenetic factor, lncRNAs can use a wide variety of molecular mechanisms to regulate gene expression at each step of the genetic information flow pathway. LncRNAs display widespread effects on cell behavior, tumor growth, and metastasis. They act intracellularly and extracellularly in an autocrine, paracrine and endocrine fashion. Increased understanding of lncRNA's role in cancer has facilitated the development of novel biomarkers for cancer diagnosis, led to greater understanding of cancer prognosis, enabled better prediction of therapeutic responses, and promoted identification of potential targets for cancer therapy.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Epigenetics; Gene expression; Gene regulation; LncRNA; Prostate cancer

Mesh:

Substances:

Year:  2021        PMID: 35152976     DOI: 10.1016/bs.acc.2021.09.005

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  2 in total

Review 1.  Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics.

Authors:  Elżbieta Wanowska; Klaudia Samorowska; Michał Wojciech Szcześniak
Journal:  Front Cell Dev Biol       Date:  2022-07-05

2.  LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis.

Authors:  Jia Yu; Xinxin Zhang; Rongfang He; Xiaoyan Yang; Juan Hu; Fang Tan; Jinyu Yao; Xiaoyong Lei; Gebo Wen
Journal:  Dis Markers       Date:  2022-07-25       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.